anidulafungin has been researched along with epiglucan in 12 studies
| Studies (anidulafungin) | Trials (anidulafungin) | Recent Studies (post-2010) (anidulafungin) | Studies (epiglucan) | Trials (epiglucan) | Recent Studies (post-2010) (epiglucan) |
|---|---|---|---|---|---|
| 568 | 33 | 331 | 5,066 | 241 | 3,169 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morrison, VA | 1 |
| Bennett, JE | 1 |
| Chen, E; Ostrosky-Zeichner, L; Paetznick, VL; Rodriguez, J; Sheehan, DJ | 1 |
| Cuenca-Estrella, M; Gurguí, M | 1 |
| Martín Mazuelos, E; Rodríguez-Tudela, JL | 1 |
| Andes, D; Arendrup, MC; Brown, SD; Diekema, DJ; Lockhart, SR; Motyl, M; Perlin, DS; Pfaller, MA | 1 |
| Edlind, TD; Johnson, ME; Katiyar, SK | 1 |
| Calvo, E; Carrillo, AJ; Guarro, J; Mayayo, E; Pastor, FJ; Quindós, G; Salas, V | 1 |
| Bocanegra, R; Kirkpatrick, WR; Najvar, LK; Patterson, TF; Wiederhold, NP | 1 |
| Jaijakul, S; Ostrosky-Zeichner, L; Swanson, RN; Vazquez, JA | 1 |
| Alexander, BD; Balch, AH; Hanson, KE; Lease, ED; Perfect, JR; Pfeiffer, CD; Zaas, AK | 1 |
| Chlebicki, MP; Kwa, AL; Lee, W; Liew, YX; Ngan, CC; Tan, AL; Teo, J; Too, IA | 1 |
5 review(s) available for anidulafungin and epiglucan
| Article | Year |
|---|---|
Echinocandin antifungals: review and update.
Topics: Anidulafungin; Animals; Antifungal Agents; beta-Glucans; Caspofungin; Echinocandins; Fungal Proteins; Humans; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic | 2006 |
Echinocandins for candidemia in adults without neutropenia.
Topics: Anidulafungin; Antifungal Agents; beta-Glucans; Candida; Candidiasis; Caspofungin; Cross Infection; Echinocandins; Fungemia; Humans; Infusions, Intravenous; Lipopeptides; Lipoproteins; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Peptides, Cyclic; Practice Guidelines as Topic | 2006 |
[Current status of invasive fungal infections. New diagnostic techniques and antifungal agents].
Topics: Anidulafungin; Antifungal Agents; Aspergillosis; beta-Glucans; Candidiasis; Clinical Trials as Topic; Critical Care; Diabetes Complications; Disease Susceptibility; Echinocandins; Fungemia; Galactose; Hematologic Diseases; Humans; Immunocompromised Host; Mannans; Meta-Analysis as Topic; Mycoses; Neoplasms; Opportunistic Infections | 2008 |
[In vitro activity of anidulafungin. Comparison with the activity of other echinocandins].
Topics: Anidulafungin; Antifungal Agents; Aspergillus; beta-Glucans; Candida; Caspofungin; Drug Resistance, Fungal; Drug Synergism; Echinocandins; Fungal Proteins; Glucosyltransferases; In Vitro Techniques; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Species Specificity | 2008 |
Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria.
Topics: Anidulafungin; Antifungal Agents; beta-Glucans; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Glucosyltransferases; Humans; Inhibitory Concentration 50; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mutation; Proteoglycans; Randomized Controlled Trials as Topic; Species Specificity; Treatment Outcome | 2011 |
2 trial(s) available for anidulafungin and epiglucan
| Article | Year |
|---|---|
(1,3)-β-D-glucan as a prognostic marker of treatment response in invasive candidiasis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; beta-Glucans; Biomarkers; Candidemia; Candidiasis, Invasive; Echinocandins; Female; Humans; Male; Middle Aged; Proteoglycans; ROC Curve; Treatment Outcome | 2012 |
β-D-glucan surveillance with preemptive anidulafungin for invasive candidiasis in intensive care unit patients: a randomized pilot study.
Topics: Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; beta-Glucans; Candidiasis, Invasive; Demography; Echinocandins; False Positive Reactions; Feasibility Studies; Female; Humans; Intensive Care Units; Kinetics; Male; Middle Aged; Pilot Projects; Predictive Value of Tests; Time Factors; Young Adult | 2012 |
5 other study(ies) available for anidulafungin and epiglucan
| Article | Year |
|---|---|
Activity of anidulafungin in a murine model of Candida krusei infection: evaluation of mortality and disease burden by quantitative tissue cultures and measurement of serum (1,3)-beta-D-glucan levels.
Topics: Anidulafungin; Animals; Antifungal Agents; beta-Glucans; Candida; Candidiasis; Disease Models, Animal; Echinocandins; Kidney; Male; Mice | 2009 |
New Fks hot spot for acquired echinocandin resistance in Saccharomyces cerevisiae and its contribution to intrinsic resistance of Scedosporium species.
Topics: Anidulafungin; Antifungal Agents; Base Sequence; beta-Glucans; Candida glabrata; Caspofungin; Cell Wall; Drug Resistance, Fungal; Echinocandins; Glucosyltransferases; Lipopeptides; Membrane Proteins; Micafungin; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Proteoglycans; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Scedosporium; Sequence Alignment; Sequence Analysis, DNA | 2011 |
Anidulafungin in treatment of experimental invasive infection by Candida parapsilosis: in vitro activity, (1-->3)-beta-D-glucan and mannan serum levels, histopathological findings, and in vivo efficacy.
Topics: Anidulafungin; Animals; Antifungal Agents; beta-Glucans; Candida; Candidiasis; Echinocandins; Kaplan-Meier Estimate; Male; Mannans; Mice; Microbial Sensitivity Tests | 2011 |
Comparison of anidulafungin's and fluconazole's in vivo activity in neutropenic and non-neutropenic models of invasive candidiasis.
Topics: Anidulafungin; Animals; Antifungal Agents; beta-Glucans; Blood; Blood Chemical Analysis; Candida albicans; Candidiasis, Invasive; Colony Count, Microbial; Disease Models, Animal; Echinocandins; Fluconazole; Mice; Mice, Inbred ICR; Neutropenia; Proteoglycans; Survival Analysis; Treatment Outcome | 2012 |
Candida Surveillance in Surgical Intensive Care Unit (SICU) in a Tertiary Institution.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Anidulafungin; Antifungal Agents; beta-Glucans; Candida; Candida albicans; Candida glabrata; Candidiasis; Candidiasis, Invasive; Carrier State; Caspofungin; Critical Care; Echinocandins; Female; Fluconazole; Humans; Incidence; Intensive Care Units; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Sensitivity and Specificity; Singapore; Tertiary Care Centers; Voriconazole | 2015 |